Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1976 1
1980 1
1994 1
1996 1
1998 1
2000 1
2002 2
2003 1
2004 1
2005 3
2006 1
2007 2
2008 1
2009 1
2011 2
2012 1
2013 1
2015 1
2016 1
2017 2
2019 2
2020 3
2021 5
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
STARRT-AKI Investigators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group; United Kingdom Critical Care Research Group; Canadian Nephrology Trials Network; Irish Critical Care Trials Group; Bagshaw SM, Wald R, Adhikari NKJ, Bellomo R, da Costa BR, Dreyfuss D, Du B, Gallagher MP, Gaudry S, Hoste EA, Lamontagne F, Joannidis M, Landoni G, Liu KD, McAuley DF, McGuinness SP, Neyra JA, Nichol AD, Ostermann M, Palevsky PM, Pettilä V, Quenot JP, Qiu H, Rochwerg B, Schneider AG, Smith OM, Thomé F, Thorpe KE, Vaara S, Weir M, Wang AY, Young P, Zarbock A. STARRT-AKI Investigators, et al. N Engl J Med. 2020 Jul 16;383(3):240-251. doi: 10.1056/NEJMoa2000741. N Engl J Med. 2020. PMID: 32668114 Free article. Clinical Trial.
Variation in prognosis and treatment outcome in juvenile myoclonic epilepsy: a Biology of Juvenile Myoclonic Epilepsy Consortium proposal for a practical definition and stratified medicine classifications.
Rubboli G, Beier CP, Selmer KK, Syvertsen M, Shakeshaft A, Collingwood A, Hall A, Andrade DM, Fong CY, Gesche J, Greenberg DA, Hamandi K, Lim KS, Ng CC, Orsini A; BIOJUME Consortium; Striano P, Thomas RH, Zarubova J, Richardson MP, Strug LJ, Pal DK. Rubboli G, et al. Brain Commun. 2023 Jun 9;5(3):fcad182. doi: 10.1093/braincomms/fcad182. eCollection 2023. Brain Commun. 2023. PMID: 37361715 Free PMC article. Review.
Hepatitis C prevalence--a nationwide serosurvey.
Amin J, Gidding H, Gilbert G, Backhouse J, Kaldor J, Dore G, Burgess M. Amin J, et al. Commun Dis Intell Q Rep. 2004;28(4):517-21. Commun Dis Intell Q Rep. 2004. PMID: 15745402 Free article.
Hepatitis C is the most commonly notified disease in Australia. In 1998 the Hepatitis C Virus Projections Working Group (HCPWG) estimated that there were approximately 210,000 people who had been infected by hepatitis C virus (HCV) in Australia by 2001. ...
Hepatitis C is the most commonly notified disease in Australia. In 1998 the Hepatitis C Virus Projections Working Group (HCPWG …
Antimicrobial activity of isopteropodine.
García R, Cayunao C, Bocic R, Backhouse N, Delporte C, Zaldivar M, Erazo S. García R, et al. Z Naturforsch C J Biosci. 2005 May-Jun;60(5-6):385-8. doi: 10.1515/znc-2005-5-603. Z Naturforsch C J Biosci. 2005. PMID: 16042336 Free article.
Inoculum production of Phytophthora medicaginis can be used to screen for partial resistance in chickpea genotypes.
Bithell SL, Drenth A, Backhouse D, Harden S, Hobson K. Bithell SL, et al. Front Plant Sci. 2023 Feb 20;14:1115417. doi: 10.3389/fpls.2023.1115417. eCollection 2023. Front Plant Sci. 2023. PMID: 36890901 Free PMC article.
Resistance based on chickpea-Cicer echinospermum crosses is partial with a quantitative genetic basis provided by C. echinospermum and some disease tolerance traits originating from C. arietinum germplasm. ...Our results showed reduced inoculum production in a C …
Resistance based on chickpea-Cicer echinospermum crosses is partial with a quantitative genetic basis provided by C. echinospermum an …
Cystectomy outcomes in patients who have failed Radiofrequency-induced Thermo-chemotherapeutic Effect Mitomycin-C (RITE-MMC) treatment for high-risk non-muscle invasive bladder cancer (HRNMIBC)-Does it complicate surgery and adversely impact oncological outcome?
Sri D, Lee HJ, El-Gemmal S, Backhouse C, Tay A, John B, Perry MJ, Ayres BE, Issa R. Sri D, et al. Urol Oncol. 2021 May;39(5):300.e15-300.e20. doi: 10.1016/j.urolonc.2020.09.016. Epub 2020 Oct 6. Urol Oncol. 2021. PMID: 33032922
Field-testing and validation in a primary care setting of a point-of-care test for C-reactive protein.
Seamark DA, Backhouse SN, Powell R. Seamark DA, et al. Ann Clin Biochem. 2003 Mar;40(Pt 2):178-80. doi: 10.1258/000456303763046139. Ann Clin Biochem. 2003. PMID: 12662408
There is a need for high-quality field evaluation of POCT before deployment can be considered. METHOD: A POCT system for C-reactive protein was evaluated in a routine general practice setting. ...
There is a need for high-quality field evaluation of POCT before deployment can be considered. METHOD: A POCT system for C-reactive p …
Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia.
Backhouse JL, Gidding HF, MacIntyre CR, McIntyre PB, Gilbert GL. Backhouse JL, et al. Vaccine. 2007 Jan 26;25(7):1310-5. doi: 10.1016/j.vaccine.2006.09.087. Epub 2006 Oct 10. Vaccine. 2007. PMID: 17069937
Neisseria meningitidis serogroup C (NMC) conjugate vaccine was introduced, in Australia, in 2003. ...
Neisseria meningitidis serogroup C (NMC) conjugate vaccine was introduced, in Australia, in 2003. ...
First measurement of neutrino oscillation parameters using neutrinos and antineutrinos by NOvA.
Acero MA, Adamson P, Aliaga L, Alion T, Allakhverdian V, Altakarli S, Anfimov N, Antoshkin A, Aurisano A, Back A, Backhouse C, Baird M, Balashov N, Baldi P, Bambah BA, Bashar S, Bays K, Bending S, Bernstein R, Bhatnagar V, Bhuyan B, Bian J, Blackburn T, Blair J, Booth AC, Bour P, Bromberg C, Buchanan N, Butkevich A, Calvez S, Campbell M, Carroll TJ, Catano-Mur E, Cedeno A, Childress S, Choudhary BC, Chowdhury B, Coan TE, Colo M, Cooper J, Corwin L, Cremonesi L, Davies GS, Derwent PF, Ding P, Djurcic Z, Doyle D, Dukes EC, Duyang H, Edayath S, Ehrlich R, Elkins M, Feldman GJ, Filip P, Flanagan W, Frank MJ, Gallagher HR, Gandrajula R, Gao F, Germani S, Giri A, Gomes RA, Goodman MC, Grichine V, Groh M, Group R, Guo B, Habig A, Hakl F, Hartnell J, Hatcher R, Hatzikoutelis A, Heller K, Hewes J, Himmel A, Holin A, Howard B, Huang J, Hylen J, Jediny F, Johnson C, Judah M, Kakorin I, Kalra D, Kaplan DM, Keloth R, Klimov O, Koerner LW, Kolupaeva L, Kotelnikov S, Kourbanis I, Kreymer A, Kulenberg C, Kumar A, Kuruppu CD, Kus V, Lackey T, Lang K, Lin S, Lokajicek M, Lozier J, Luchuk S, Maan K, Magill S, Mann WA, Marshak ML, Martinez-Casales M, Matveev V, Méndez DP, Messier MD, Meyer H, Miao T,… See abstract for full author list ➔ Acero MA, et al. Phys Rev Lett. 2019 Oct 11;123(15):151803. doi: 10.1103/PhysRevLett.123.151803. Phys Rev Lett. 2019. PMID: 31702305
This new antineutrino data are combined with neutrino data to measure the parameters |deltam_{32}^{2}|=2.48_{-0.06}^{+0.11}10^{-3} eV^{2}/c^{4} and sin^{2}teta_{23} in the ranges from (0.53-0.60) and (0.45-0.48) in the normal neutrino mass hierarchy. ...
This new antineutrino data are combined with neutrino data to measure the parameters |deltam_{32}^{2}|=2.48_{-0.06}^{+0.11}10^{-3} eV^{2}/ …
40 results